Alpha Paradigm Partners »

Halozyme Therapeutics shares owned by Alpha Paradigm Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Alpha Paradigm Partners from 13F filings

Historical chart of Alpha Paradigm Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Alpha Paradigm Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Alpha Paradigm Partners

Quarter filed Position value Share count Share price at filing
2022-12-31 $362k 6.4k 56.95
2022-09-30 $913k 23k 39.53